Filtered By:
Procedure: Dialysis
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 42797 results found since Jan 2013.
Path Analysis on Medical Expenditures of 855 Patients with Chronic Kidney Disease in a Hospital in Beijing.
CONCLUSIONS: It is suggested that the type of dialysis and the admission of ICU were the major influencing factors of inpatient medical expenditures on CKD patients, and should be taken into consideration into the reassessment of DRGs grouping process to realize the localization and generalization of prospective payment system based on DRGs within the regional area and promote the implementation of medical cost control measures to reduce the economic burdens among patients and the society.
PMID: 29271376 [PubMed - in process]
Source: Chinese Medical Journal - December 24, 2017 Category: General Medicine Authors: Liu X, Mao YH, Wang HT, Chen XG, Zhao B, Sun Y Tags: Chin Med J (Engl) Source Type: research
Laminate Medical launches study of VasQ hemodialysis fistula device
Laminate Medical Technologies said today it launched a pivotal, FDA-cleared trial of its VasQ implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis.
The Israel-based company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The device regulates flow by constraining and shaping the fistula and reinforces and shields the perianastomotic vein against high pressure, wall tension and flow levels, the company said.
The first procedures in the trial were recently performed by Dr...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Vascular Laminate Medical Technologies Source Type: news
The Quality of Life of Hemodialysis Patients Is Affected Not Only by Medical but also Psychosocial Factors: a Canonical Correlation Study.
CONCLUSION: Psychosocial factors influence QoL in patients with ESRD, and should thus be carefully considered when caring for these patients in clinical practice.
PMID: 29607636 [PubMed - in process]
Source: Journal of Korean Medical Science - April 4, 2018 Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
FDA grants de novo clearance to hemodialysis catheters from Avenu Medical, TVA Medical
The FDA today granted de novo clearance to a pair of companies that make catheters designed for hemodialysis, Avenu Medical and TVA Medical.
The federal safety watchdog said the catheters are designed to create an arteriovenous fistula connecting veins and arteries for a less-invasive way to access the vascular system. Avenu’s device is called Ellipsys; TVA Medical makes the EverlinQ EndoAVF system.
“Dialysis is a necessary and life-saving procedure for thousands of individuals. With today’s action, there will be additional, less-invasive vascular access options for patients who will require hemodialysis...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Catheters Dialysis Food & Drug Administration (FDA) Regulatory/Compliance Avenu Medical TVA Medical Source Type: news
Outset Medical closes $132m Series D funding round
Outset Medical said today it raised $132 million in a Series D round of equity financing, with funds slated to accelerate the commercial expansion of its Tablo hemodialysis system.
The San Jose, Calif.-based company develops and produces the Tablo hemodialysis system, an all-in-1 dialysis machine designed to handle water purification and dialysate production and be used in a variety of different settings.
The round was led by the newly invested Mubadala Investment Company and joined by existing investors Baxter Ventures, Fidelity Management and Research Company, Partner Fund Management LP, Perceptive Advisors, funds advise...
Source: Mass Device - August 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Funding Roundup Outset Medical Source Type: news
Laminate Medical brings in $12m for dialysis vascular support device
Israeli medtech start-up Laminate Medical Technologies said today that it raised $12 million in a new round of financing slated to support its VasQ vascular support device.
The company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure.
The VasQ regulates flow by constraining and shaping optimal geometrical parameters of the fistula, the company said, and reinforces and shields the vulnerable perianastomotic vein against high pressure, wall tension and flow levels.
The round was joined by Asahi Kasei (TYO:3407) and Tal Capital, as well as...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Dialysis Featured Vascular Laminate Medical Technologies Source Type: news
Cantel Medical slumps on fiscal Q2 misses
Cantel Medical (NYSE:CMD) shares took a hit this week when the medical device company missed the consensus forecast with its fiscal second-quarter results.
Little Falls, N.J.-based Cantel posted a -42.1% profit slide to $18.8 million, or 45¢ per share, on sales of $224.5 million for the three months ended Jan. 31, for top-line growth of 5.4% compared with fiscal Q2 2018.
Adjusted to exclude one-time items, earnings per share were 57¢, a nickel below the consensus on Wall Street, where analysts were looking for revenues of $226.9 million.
“We are pleased to see continued strong double-digit sales growth in our medi...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat Cantel Medical Corp. Source Type: news
Brookhaven Medical, Inc. To Acquire Wound Management Technologies
Brookhaven Medical, Inc., an Atlanta-based medical device company with interests in dialysis devices and advanced wound care, recently announced an agreement to acquire Wound Management Technologies, Inc. of Fort Worth, an emerging commercial stage company focused on the worldwide advanced wound care market.
Source: Medical Design Online News - October 17, 2013 Category: Medical Equipment Source Type: news
NxStage Medical's Q4 prelims beat its own, Wall Street's forecasts
NxStage Medical's shares are up today after the medical device company beats its own and Wall Street's expectations with its preliminary 4th-quarter sales numbers.
NxStage Medical (NSDQ:NXTM) saw its stock price climb this morning after reporting preliminary 4th-quarter sales numbers that topped its own forecast and handily beat expectations on Wall Street.
News Well, J.P. Morgan Healthcare Conference, MassDevice.com Earnings Roundup, 2013, Dialysis, Q4read more
Source: Mass Device - January 14, 2014 Category: Medical Equipment Authors: Brad Perriello Tags: NxStage Medical Inc. Source Type: news
Clinical Experience of Life-Threatening Dabigatran-Related Bleeding at a Large, Tertiary Care, Academic Medical Center: a Case Series.
CONCLUSION: Reversal strategies for dabigatran-related bleeding events at our institution are highly variable. Intracranial hemorrhage in patients on dabigatran was associated with 43 % mortality. Patients with severe dabigatran-related bleeding may benefit from a standardized approach to treatment.
PMID: 24385325 [PubMed - as supplied by publisher]
Source: Journal of Medical Toxicology - January 3, 2014 Category: Toxicology Authors: Ross B, Miller MA, Ditch K, Tran M Tags: J Med Toxicol Source Type: research
Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
CONCLUSION: MT is a safe procedure with high diagnostic yields in undiagnosed pleural effusions. TTP is an effective method to stop recurrence of pleural effusions.
PMID: 26034319 [PubMed - in process]
Source: Singapore Medical Journal - May 1, 2015 Category: Journals (General) Authors: Verma A, Taha A, Venkateswaran S, Tee A Tags: Singapore Med J Source Type: research
AV Medical wins FDA 510(k) for Chameleon balloon catheter
Israel based AV Medical said today it won FDA 510(k) clearance for its Chameleon angioplasty balloon catheter.
The company’s Chameleon catheter comes equipped with proximal injection port technology which the company claims make it the 1st and only angioplasty balloon catheter that allows for simultaneous balloon inflation and injection of intravascular fluids during guidewire access.
“Our entire team is thrilled with this news. Chameleon represents the first product to include our proprietary Proximal Injection Port design. We look forward to bringing Chameleon to the dialysis access market in the United State...
Source: Mass Device - October 26, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Vascular AV Medical Source Type: news
NxStage Medical jumps on Q3 beat-and-raise, reveals pipeline
NxStage Medical (NSDQ:NXTM) shares started up today as investors reacted to beat-and-raise results for the home hemodialysis company’s 3rd-quarter and details about its development pipeline.
Lawrence, Mass.-based NxStage said it narrowed its losses by -47.8% to -$1.7 million, or -3¢ per share, on sales growth of 14.9% to $86.5 million compared with Q3 2014. The consensus outlook on Wall Street was for losses of -8¢ on sales of $82.1 million.
“Based on our performance and confidence around the 4th quarter, we are again raising our total revenue guidance for the year,” founder & CEO Jeffrey Burbank ...
Source: Mass Device - November 3, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis MassDevice Earnings Roundup Wall Street Beat NxStage Medical Inc. Source Type: news
ExThera Medical Announces Initiation Of Clinical Trials Of Its Seraph Microbind Affinity Blood Filter (Seraph)
ExThera Medical Corporation has received approval of its CE mark clinical trial protocol from Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), the German Competent Authority. This approval, together with approval of the Ethics Committee of Hannover Medical School (also received), allows the company to begin its CE mark study, in which Seraph will be used to treat dialysis patients who haveStaphylococcus aureusand MRSA bloodstream infections.
Source: Medical Design Online News - December 8, 2015 Category: Medical Equipment Source Type: news
Exthera Medical closes $15 million Series B for Seraph blood infection filter
Updated to correct funding amounts and include new information from Exthera.
By Fink Densford & Varun Saxena
Martinez, Calif.-based Exthera Medical said it raised a $15.3 million Series B round following positive tests of its CE-Marked Seraph blood filter in animal studies.
The company’s Seraph microbind affinity blood filter is designed to remove a range of sepsis-causing bacteria, virusses, toxins and pro-inflammatory cytokines from blood. The device is currently under evaluation in a 1st-in-man clinical trial in Europe.
Funds from the round will support European and U.S. clinical trials and the pursuit of r...
Source: Mass Device - June 2, 2016 Category: Medical Equipment Authors: Varun Saxena Tags: Blood Management Funding Roundup ExThera Medical Source Type: news
